Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 19Sarcoma 7Lymphoid 7Myeloid 6Genitourinary 6Gastrointestinal 6NET 2Endocrine 2

Conditions

Neuroendocrine Tumors 15Thyroid Neoplasms 3Gastro-enteropancreatic neuroendocrine tumor 3Brain Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Testicular Neoplasms 2Prostatic Neoplasms 2Paraganglioma 2Neuroblastoma 2Cholangiocarcinoma 2Carcinoma, Transitional Cell 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Adrenal Gland Neoplasms 2Adenoma, Islet Cell 2von Hippel-Lindau Disease 1Vaginal Neoplasms 1Uveal Melanoma 1Uterine Neoplasms 1Thymus Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Solitary Fibrous Tumors 1Skin Neoplasms 1Sarcoma 1Salivary Gland Neoplasms 1Pheochromocytoma 1Penile Neoplasms 1

Interventions

gallium Ga 68 dotatate 4fluorodopa F 18 2Magnetic Resonance Spectroscopy 2pertuzumab 1pentetreotide 1olaparib 1lutetium Lu 177 dotatate 1arginyllysine 1Whole Body Imaging 1Tretinoin 1Nivolumab 1Isotretinoin 1Furosemide 1Erlotinib Hydrochloride 1Amino Acids 190Y-octreotide, DOTA-Tyr(3)- 14-chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid 13-fluorobenzylguanidine 1(18F)GTP1 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neuroblastoma × Magnetic Resonance Spectroscopy × NET × Clear all
NCT01869725 2021-09-22

Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT

University of Iowa

Phase 2 Completed
68 enrolled 8 charts
CNSEndocrineNET

Medulloblastoma, Neuroblastoma, Somatostatinoma, Neuroendocrine Tumors

NCT02177773 2019-11-12

DOTA-TOC

University of California, San Francisco

Phase 1/2 Terminated
300 enrolled 5 charts
CNSEndocrineNET

Carcinoid Tumor, Neuroblastoma, Paraganglioma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡